Aidigong Maternal & Child Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Aidigong Maternal & Child Health şirketinin kazançları yıllık ortalama -17.5% oranında azalırken, Healthcare sektörünün kazançları yıllık 11.2% oranında artan oldu. Gelirler yıllık ortalama 1.3% oranında artan oldu.

Anahtar bilgiler

-17.5%

Kazanç büyüme oranı

-14.1%

EPS büyüme oranı

Healthcare Sektör Büyümesi	11.3%
Gelir büyüme oranı	1.3%
Özkaynak getirisi	-25.5%
Net Marj	-37.0%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Sep 25

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Jun 06

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Mar 22

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Jul 06

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Jun 14

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Mar 27

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Dec 21

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

Oct 13

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Sep 02

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Jun 29

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

Aug 31

Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

Feb 21

Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

Jan 17

Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

Dec 12

Gelir ve Gider Dağılımı

Aidigong Maternal & Child Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SEHK:286 Gelir, gider ve kazançlar (HKD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	522	-193	261
31 Mar 24	538	-185	259
31 Dec 23	555	-177	257
30 Sep 23	606	-152	257
30 Jun 23	658	-127	257
31 Mar 23	669	-146	263
31 Dec 22	680	-165	269
30 Sep 22	664	-123	225
30 Jun 22	647	-80	181
31 Mar 22	645	-37	176
31 Dec 21	643	5	171
30 Sep 21	622	-189	178
30 Jun 21	601	-384	186
31 Mar 21	601	-383	178
31 Dec 20	601	-381	171
30 Sep 20	653	-172	169
30 Jun 20	704	37	167
31 Mar 20	657	24	145
31 Dec 19	611	11	123
30 Sep 19	492	3	92
30 Jun 19	374	-5	60
31 Mar 19	376	-1	63
31 Dec 18	377	2	65
30 Sep 18	452	2	64
30 Jun 18	528	3	64
31 Mar 18	501	2	54
31 Dec 17	475	1	45
30 Sep 17	496	8	43
30 Jun 17	517	14	41
31 Mar 17	536	28	45
31 Dec 16	555	42	49
30 Sep 16	583	51	45
30 Jun 16	610	59	41
31 Mar 16	570	47	37
31 Dec 15	530	34	32
30 Jun 15	485	27	38
31 Mar 15	422	24	35
31 Dec 14	360	20	33
30 Jun 14	17	-10	18
31 Mar 14	13	-6	15
31 Dec 13	9	-3	12

Kaliteli Kazançlar: 286 şu anda kârlı değil.

Büyüyen Kar Marjı: 286 şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 286 kârlı değildir ve zararlar son 5 yılda yılda 17.5% oranında artmıştır.

Büyüme Hızlandırma: 286 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: 286 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( -16.9% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: 286 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -25.5% ) sahiptir.

Aidigong Maternal & Child Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

Aidigong Maternal & Child Health Limited to Report First Half, 2024 Results on Aug 30, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Aidigong Maternal & Child Health Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

Recent updates

Now 33% undervalued

Now 26% undervalued

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

New minor risk - Share price stability

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Aidigong Maternal & Child Health Limited(SEHK:286) dropped from S&P Global BMI Index

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

Aidigong Maternal & Child Health Limited to Report First Half, 2024 Results on Aug 30, 2024

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2024

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Aidigong Maternal & Child Health Limited has filed a Follow-on Equity Offering in the amount of HKD 62.09021 million.

Aidigong Maternal & Child Health Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

New minor risk - Insider selling

Chairman & CEO recently sold HK$8.4m worth of stock

New major risk - Share price stability

Chairman & CEO recently bought HK$1.4m worth of stock

New minor risk - Shareholder dilution

Chairman of the Board & CEO recently bought HK$247k worth of stock

Aidigong Maternal & Child Health Limited Announces Board and Committee Changes

Aidigong Maternal & Child Health Limited Announces Resignation of Guo Qifei Has as Non-Executive Director

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

Aidigong Maternal & Child Health Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023

Aidigong Maternal & Child Health Limited to Report First Half, 2023 Results on Aug 31, 2023

Executive Director recently bought HK$6.3m worth of stock

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Full year 2022 earnings: EPS and revenues miss analyst expectations

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Now 22% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Director Appointments

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Aidigong Maternal & Child Health Limited announced that it expects to receive HKD 224.719102 million in funding from Zhuhai Deyou Bohui Enterprise Management Consulting (Limited Partnership)

Now 24% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Executive Changes

Price target decreased to HK$0.60

Less than half of directors are independent

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Now 25% undervalued

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Aidigong Maternal & Child Health Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Wong Kin Man as a Non-Executive Director

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Yang Zhibo as Non-Executive Director

Price target decreased to HK$0.65

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Chairman of the Board & CEO recently bought HK$1.2m worth of stock

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Independent Non Executive Director Yang Guang Mai has left the company

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Aidigong Maternal & Child Health Limited has completed a Follow-on Equity Offering in the amount of HKD 117.8 million.

An unknown buyer entered into an agreement to acquire 49% stake Shenzhen Wanqi Marine Bio Tech Company Limited from Aidigong Maternal & Child Health Limited (SEHK:286) for HKD 25 million.

Full year 2020 earnings released: HK$0.10 loss per share (vs HK$0.004 profit in FY 2019)

Aidigong Maternal & Child Health Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

New 90-day high: HK$0.62

Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

New 90-day low: HK$0.45

Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

New 90-day low: HK$0.50

New 90-day low: HK$0.52

New 90-day low: HK$0.56